Business Description
Avai Bio Inc
NAICS : 513210
SIC : 7371
ISIN : US89487B1008
Total Employee Number:
1Description
Avai Bio Inc is a biotechnology company focused on identifying genetically modified cell lines, and through joint venture and licensing agreements, developing cell-based therapies. The company has two development programs in its cellular therapies pipeline, a diabetes development program to advance a treatment for type 1 and type 2 insulin-dependent diabetes, and an ?-Klotho protein development program to advance therapies for age-related diseases and anti-aging treatments.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.03 | |||||
Equity-to-Asset | -16.15 | |||||
Debt-to-Equity | -0.56 | |||||
Debt-to-EBITDA | -1.58 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -38.7 | |||||
3-Year EPS without NRI Growth Rate | -26 | |||||
3-Year FCF Growth Rate | 23.4 | |||||
3-Year Book Growth Rate | 9.1 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 48.58 | |||||
9-Day RSI | 42.81 | |||||
14-Day RSI | 39.56 | |||||
3-1 Month Momentum % | -40.02 | |||||
6-1 Month Momentum % | -28.21 | |||||
12-1 Month Momentum % | -61.82 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.02 | |||||
Quick Ratio | 0.02 | |||||
Cash Ratio | 0.02 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -73.5 | |||||
Shareholder Yield % | -3.23 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROA % | -543.2 | |||||
ROIC % | -83.33 | |||||
3-Year ROIIC % | -409.27 | |||||
Moat Score | 2 | |||||
Tariff Resilience Score | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | N/A |
N/A
|
N/A
| |||
PE Ratio without NRI | N/A |
N/A
|
N/A
| |||
EV-to-EBIT | -22.15 | |||||
EV-to-EBITDA | -22.97 | |||||
EV-to-FCF | -19.91 | |||||
Earnings Yield (Greenblatt) % | -4.51 | |||||
FCF Yield % | -5.39 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:AVAI
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Avai Bio Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | - | ||
| Beta | 0.9617 | ||
| 3-Year Sharpe Ratio | -0.11 | ||
| 3-Year Sortino Ratio | -0.19 | ||
| Volatility % | 94.2 | ||
| 14-Day RSI | 39.56 | ||
| 14-Day ATR ($) | 0.030351 | ||
| 20-Day SMA ($) | 0.169141 | ||
| 12-1 Month Momentum % | -61.82 | ||
| 52-Week Range ($) | 0.14 - 0.8 | ||
| Shares Outstanding (Mil) | 138.25 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Avai Bio Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Avai Bio Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Second quarter earnings results for 2027 | 2026-11-13 | In 137 days | ||
| First quarter earnings results for 2027 | 2026-08-12 | In 44 days | ||
| General meeting for 2025 | 2026-07-20 | In 21 days | ||
| Annual report for 2026 | 2026-07-08 | In 9 days | ||
| Third quarter earnings results for 2026 | 2026-02-12 | 0.38 (+0.82%) | ||
| Second quarter earnings results for 2026 | 2025-11-14 | 0.35 (-3.22%) | ||
| First quarter earnings results for 2026 | 2025-08-12 | 0.54 (-6.82%) | ||
| Annual report for 2025 | 2025-07-08 | 0.53 (-1.01%) | ||
| Third quarter earnings results for 2025 | 2025-02-07 | 0.61 (-0.95%) | ||
| Second quarter earnings results for 2025 | 2024-11-12 | 0.29 (+7.41%) |
Show
Entries
Avai Bio Inc Frequently Asked Questions
What is Avai Bio Inc(AVAI)'s stock price today?
The current price of AVAI is $0.15. The 52 week high of AVAI is $0.80 and 52 week low is $0.14.
When is next earnings date of Avai Bio Inc(AVAI)?
The next earnings date of Avai Bio Inc(AVAI) is 2026-08-12 Est..
Does Avai Bio Inc(AVAI) pay dividends? If so, how much?
Avai Bio Inc(AVAI) does not pay dividend.
Guru Commentaries on OTCPK:AVAI
No articles.
Press Release
Articles on Avai Bio Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers